The renal phenotype of allopurinol-treated HPRT-deficient mouse.
Excess of uric acid is mainly treated with xanthine oxidase (XO) inhibitors, also called uricostatics because they block the conversion of hypoxanthine and xanthine into urate. Normally, accumulation of upstream metabolites is prevented by the hypoxanthine-guanine phosphoribosyltransferase (HPRT) en...
Saved in:
| Main Authors: | Cristina Zennaro, Federica Tonon, Paola Zarattini, Milan Clai, Alessandro Corbelli, Michele Carraro, Marialaura Marchetti, Luca Ronda, Gianluca Paredi, Maria Pia Rastaldi, Riccardo Percudani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0173512&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gene Expression Analysis of HPRT-Deficient Cells Maintained with Physiological Levels of Folic Acid
by: Rosa J. Torres, et al.
Published: (2025-07-01) -
Allopurinol in the complex therapy of acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01) -
A Case of DILI and Subsequent HLH Induced by Allopurinol
by: Edward Butt, et al.
Published: (2022-10-01) -
Ameliorative Effect of Allopurinol on Vascular Complications of Insulin Resistance
by: Hany M. El-Bassossy, et al.
Published: (2015-01-01) -
Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study
by: Mai O Kadry, et al.
Published: (2024-12-01)